Nina Harawa to Costs and Cost Analysis
This is a "connection" page, showing publications Nina Harawa has written about Costs and Cost Analysis.
Connection Strength
0.051
-
Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program. JAMA Intern Med. 2023 08 01; 183(8):885-889.
Score: 0.051
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.